Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C–H activation: Macrocyclic oxime inhibitor of influenza H1N1

MLA

Hao Wang, et al. “Multicomponent Coupling and Macrocyclization Enabled by Rh(III)-Catalyzed Dual C–H Activation: Macrocyclic Oxime Inhibitor of Influenza H1N1.” Chem, vol. 9, Mar. 2023, pp. 607–23. EBSCOhost, https://doi.org/10.1016/j.chempr.2022.10.019.

APA

Hao Wang, Zhongyu Li, Xiangyang Chen, Jonathan J. Wong, Tongyu Bi, Xiankun Tong, Zhongliang Xu, Mingyue Zhen, Yunhui Wan, Li Tang, Bo Liu, Xinlei Zong, Dandan Xu, Jianping Zuo, Li Yang, Wei Huang, Kendall N. Houk, & Weibo Yang. (2023). Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C–H activation: Macrocyclic oxime inhibitor of influenza H1N1. Chem, 9, 607–623. https://doi.org/10.1016/j.chempr.2022.10.019

Chicago

Hao Wang, Zhongyu Li, Xiangyang Chen, Jonathan J. Wong, Tongyu Bi, Xiankun Tong, Zhongliang Xu, et al. 2023. “Multicomponent Coupling and Macrocyclization Enabled by Rh(III)-Catalyzed Dual C–H Activation: Macrocyclic Oxime Inhibitor of Influenza H1N1.” Chem 9 (March): 607–23. doi:10.1016/j.chempr.2022.10.019.